Prestigious professorship awarded at the Institute of Oncology Research in Bellinzona

Stiftung Experimentelle Biomedizin has awarded Dr Arianna Calcinotto, Group Leader at the Institute of Oncology Research (IOR, affiliated to USI Università della Svizzera italiana) the Peter Hans Hofschneider Professorship 2020/2021. This is the third time the Zurich-based foundation has conferred the award in Switzerland. Arianna Calcinotto, who since 2019 heads the Cancer Immunotherapy resear...
More

IOR study reveals how breast cancer therapy may be effective against COVID-19

The so-called “Selective Estrogen Receptor Modulators (SERMs)” treatments used in breast cancer therapy may be effective against COVID-19. A study conducted by the Institute of Oncology Research (IOR, affiliated to USI) based on data obtained from the Veneto Tumor Registry (Italy) has observed a lower risk of developing the coronavirus disease for women affected by hormonal-driven cancers subje...
More

Why Specific Genetic Alterations Matter in Prostate Cancer

A given substance may be fundamental for life or may serve as a poison. All depends on the specific dose. At first glance, this somewhat paradoxical principle in medicine was first coined by the Swiss physician Paracelsus more than half a millennium ago when he stated: “All things are poison, and nothing is without poison. Solely the dose determines that a thing is not a poison”. Centuries later, ...
More